product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Bcl10 (C78F1) Rabbit mAb
catalog :
4237
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
C78F1
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation, western blot knockout validation
citations: 5
Published Application/Species/Sample/DilutionReference
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s1c
Rosenbaum M, Gewies A, Pechloff K, Heuser C, Engleitner T, Gehring T, et al. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Nat Commun. 2019;10:2352 pubmed publisher
  • western blot; mouse; loading ...; fig 5a
Lan P, Fan Y, Zhao Y, Lou X, Monsour H, Zhang X, et al. TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury. J Clin Invest. 2017;127:2222-2234 pubmed publisher
  • western blot; human; loading ...; fig 3c
Mondello P, Derenzini E, Asgari Z, Philip J, Brea E, SESHAN V, et al. Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma. Oncotarget. 2017;8:14017-14028 pubmed publisher
  • western blot; mouse; loading ...; fig 5b
Naik E, Dixit V. Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity. J Immunol. 2016;196:3438-51 pubmed publisher
Zhang Y, Liu R, Cao Q, Fan K, Huang L, Yu J, et al. USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance. J Clin Invest. 2019;129:2856-2871 pubmed publisher
product information
SKU :
4237S
Product-Name :
Bcl10 (C78F1) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, (Mk)
Applications :
Immunoprecipitation
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
28
Host :
Rabbit
Target :
BCL-10
Primary-Protein :
Bcl-10
Alt-Names :
B-cell CLL/lymphoma 10,B-cell lymphoma/leukemia 10,BCL10,Bcl-10,CARD containing molecule enhancing NF-kB,CARD-containing apoptotic signaling protein,CARD-containing molecule enhancing NF-kappa-B,CARD-containing proapoptotic protein,CARD-like apoptotic protein,CARMEN,CED-3/ICH-1 prodomain homologous E10-like regulator,CIPER,CLAP,Cellular homolog of vCARMEN,Cellular-E10,Mammalian CARD-containing adapter molecule E10,c-E10,cCARMEN,caspase-recruiting domain-containing protein,hCLAP,mE10
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.